Search

Laboratorios Farmaceuticos Rovi SA

Suletud

SektorTervishoid

58.1 0.52

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

56.3

Max

58.7

Põhinäitajad

By Trading Economics

Sissetulek

-33M

9.5M

Müük

-66M

152M

P/E

Sektori keskmine

21.027

62.58

Aktsiakasum

0.185

Kasumimarginaal

6.216

Töötajad

1,950

EBITDA

-45M

18M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+30.96% upside

Turustatistika

By TradingEconomics

Turukapital

-1.3B

2.8B

Eelmine avamishind

57.58

Eelmine sulgemishind

58.1

Uudiste sentiment

By Acuity

50%

50%

138 / 340 Pingereas Healthcare

Laboratorios Farmaceuticos Rovi SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. juuli 2026, 10:46 UTC

Social Media
News

Knight-Swift Transportation reported strong Q2 results, with revenue of $2.1 billion and adjusted EPS of $0.63, but shares are lower in pre-market trading.

23. juuli 2026, 10:46 UTC

Social Media
News
Correlated Moves

Northrop Grumman Corp secured a $1.2 billion contract for E-2D aircraft production, boosting shares in pre-market trading amid positive investor sentiment.

23. juuli 2026, 10:46 UTC

News

Blackstone Inc has launched two hybrid investment funds to expand access to alternative investments. Shares are trading higher since Wednesday's close, despite earlier losses.

23. juuli 2026, 10:46 UTC

News

Barclays lowered Pegasystems' price target to $39.00 from $48.00, maintaining an Overweight rating. Shares are trading lower in pre-market hours.

23. juuli 2026, 10:46 UTC

News
Social Media

Intel is finalizing long-term purchase commitments for data-center processors in China, driven by AI demand. Shares are higher in pre-market trading ahead of earnings.

23. juuli 2026, 10:46 UTC

News

Geopolitical tensions are impacting the US 10Y Treasury Bond Index. As a result, Vanguard Total Bond Market ETF is trading roughly flat during pre-market hours.

23. juuli 2026, 10:46 UTC

News

Community Health Systems shares lower in pre-market after Barclays cut the price target to $2.50, following a decline in net income and revenues.

23. juuli 2026, 10:42 UTC

News

Coca-Cola recognized as a top dividend stock, offering a quarterly dividend of $0.53 per share. Shares are higher in pre-market trading.

23. juuli 2026, 10:36 UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is slightly higher in pre-market trading, supported by strong performances from key holdings, despite broader market caution ahead of the ECB decision.

23. juuli 2026, 10:36 UTC

News

Schlumberger NV reports $8.72 billion in quarterly revenue, down 6.3% year-over-year. Shares advance in pre-market trading, supported by positive sector sentiment.

23. juuli 2026, 10:36 UTC

Social Media
News

General Motors shares are higher in pre-market trading following strong Q2 results and price target increases from TD Cowen and Goldman Sachs.

23. juuli 2026, 10:32 UTC

Social Media
News

Hewlett Packard Enterprise shares are higher in pre-market trading, supported by strong investor interest in AI infrastructure and positive sector sentiment following Dell's gains.

23. juuli 2026, 10:26 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF trades roughly flat in pre-market hours as major tech firms prepare to report quarterly earnings, influencing investor focus on AI and cloud growth.

23. juuli 2026, 10:26 UTC

News

Fortinet Inc. has been named Intel's first external customer for its foundry business, producing the SP6 security chip. Shares are higher in pre-market hours.

23. juuli 2026, 10:26 UTC

News
Correlated Moves

ConocoPhillips shares are higher in pre-market trading, reflecting a positive response to rising WTI crude prices amid escalating Middle East tensions.

23. juuli 2026, 10:26 UTC

News

Nasdaq Inc is advancing in pre-market trading as it prepares to implement new delisting rules for underperforming microcap companies following SEC approval.

23. juuli 2026, 10:16 UTC

News

PagSeguro Digital shares are lower in pre-market trading following Jefferies' Hold rating and price target of $10.40, after closing at $9.67.

23. juuli 2026, 10:16 UTC

News
Event

Arrowhead Pharmaceuticals shares rise in pre-market trading, building on Wednesday's gains after positive drug trial results and a price target increase to $115 from $90.

23. juuli 2026, 10:16 UTC

News

DigitalOcean Holdings sees strong demand for AI data centers, with $800 million in remaining performance obligations. Shares are higher in pre-market trading.

23. juuli 2026, 10:16 UTC

News

American Electric Power shares are lower in pre-market trading amid ongoing performance weakness, despite the appointment of two new board members.

23. juuli 2026, 10:16 UTC

Social Media
News

Netflix Inc. shares are higher in pre-market trading, supported by strong Movies & Entertainment sector performance and robust EBITDA of $8.66 billion.

23. juuli 2026, 10:16 UTC

News
Social Media

Advanced Micro Devices is finalizing long-term CPU commitments in China, driven by AI demand. Shares are higher in pre-market trading amid these developments.

23. juuli 2026, 10:16 UTC

Social Media
News
Correlated Moves

Apple Inc shares are lower in pre-market trading amid a broader market downturn and challenges in foldable iPhone production, though the launch schedule remains on track.

23. juuli 2026, 10:11 UTC

News

Autodesk shares rise in pre-market after Guggenheim Buy rating.

23. juuli 2026, 10:11 UTC

News

Southwest Airlines shares are lower in pre-market trading after the company issued third-quarter guidance below consensus and revised full-year EPS expectations downward.

23. juuli 2026, 10:11 UTC

News

American Airlines shares are trading lower in pre-market hours as higher jet fuel costs weigh on earnings projections ahead of upcoming results.

23. juuli 2026, 10:11 UTC

Social Media
News

Kinder Morgan shares are higher in pre-market trading following strong second-quarter results, including record net income of $867 million and a dividend increase to $0.2975.

23. juuli 2026, 10:11 UTC

News

Teledyne Technologies announced a five-year partnership with the Royal National Lifeboat Institution to enhance lifeboat technology. Needham raised its price target to $750.

23. juuli 2026, 10:06 UTC

Social Media
News

Micron Technology shares higher in pre-market trading following a Motley Fool prediction of $1,400 by 2027, citing strong revenue growth and strategic agreements.

23. juuli 2026, 10:06 UTC

News

EQT Corp's stock rises in pre-market trading after raising full-year natural gas production guidance and securing long-term supply agreements.

Võrdlus sarnastega

Hinnamuutus

Laboratorios Farmaceuticos Rovi SA Prognoos

Hinnasiht

By TipRanks

30.96% tõus

12 kuu keskmine prognoos

Keskmine 73.6 EUR  30.96%

Kõrge 83 EUR

Madal 64.2 EUR

Põhineb 2 Wall Streeti analüütiku instrumendi Laboratorios Farmaceuticos Rovi SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

138 / 340 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
help-icon Live chat